Latest News

1 Feb 2017 Ergomed notes co-development partner Aeterna Zentaris Completes Zoptrex™ Pivotal Phase [...]
17 Jan 2017 Ergomed to report very strong 2016 revenue growth and order [...]
20 Dec 2016 Proposed Board changes
30 Nov 2016 Award of options by Chief Executive Officer over personally owned [...]
29 Nov 2016 Ergomed strengthens PrimeVigilance with acquisition of European pharmacovigilance and regulatory [...]
16 Nov 2016 Ergomed’s co-development partner Modus Therapeutics announces that the Independent Data [...]

Previous Events

17 Nov 2020 Ergomed presenting at Jefferies Virtual London 2020 Healthcare Conference